Skip to main content
PMC home page
Journal of Clinical Pathology. Supplement (Royal College of Pathologists) logoLink to Journal of Clinical Pathology. Supplement (Royal College of Pathologists)
. 1974;8:94–105.

Sphingolipidoses

Konrad Sandhoff 1
PMCID: PMC1347206  PMID: 4157247

Full text

PDF
103

Images in this article

95Image
on p.95

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Austin J., Armstrong D., Fouch S., Mitchell C., Stumpf D., Shearer L., Briner O. Metachromatic leukodystrophy (MLD). 8. MLD in adults; diagnosis and pathogenesis. Arch Neurol. 1968 Mar;18(3):225–240. doi: 10.1001/archneur.1968.00470330015001. [DOI] [PubMed] [Google Scholar]
  2. Austin J., Armstrong D., Shearer L. Metachromatic form of diffuse cerebral sclerosis. V. The nature and significance of low sulfatase activity: a controlled study of brain, liver and kidney in four patients with metachromatic leukodystrophy (MLD). Arch Neurol. 1965 Dec;13(6):593–614. doi: 10.1001/archneur.1965.00470060029003. [DOI] [PubMed] [Google Scholar]
  3. BRADY R. O., KANFER J. N., SHAPIRO D. METABOLISM OF GLUCOCEREBROSIDES. II. EVIDENCE OF AN ENZYMATIC DEFICIENCY IN GAUCHER'S DISEASE. Biochem Biophys Res Commun. 1965 Jan 18;18:221–225. doi: 10.1016/0006-291x(65)90743-6. [DOI] [PubMed] [Google Scholar]
  4. Bowen D. M., Radin N. S. Cerebroside galactosidase: a method for determination and a comparison with other lysosomal enzymes in developing rat brain. J Neurochem. 1969 Apr;16(4):501–511. doi: 10.1111/j.1471-4159.1969.tb06849.x. [DOI] [PubMed] [Google Scholar]
  5. Brady R. O., Kanfer J. N., Bradley R. M., Shapiro D. Demonstration of a deficiency of glucocerebroside-cleaving enzyme in Gaucher's disease. J Clin Invest. 1966 Jul;45(7):1112–1115. doi: 10.1172/JCI105417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Brett E. M., Ellis R. B., Haas L., Ikonne J. U., Lake B. D., Patrick A. D., Stephens R. Late onset GM2-gangliosidosis. Clinical, pathological, and biochemical studies on 8 patients. Arch Dis Child. 1973 Oct;48(10):775–785. doi: 10.1136/adc.48.10.775. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Carroll M., Robinson D. Immunological properties of N-acetyl-beta-D-glucosaminidase of normal human liver and of GM2-gangliosidosis liver. Biochem J. 1973 Jan;131(1):91–96. doi: 10.1042/bj1310091. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dawson G., Matalon R., Li Y. T. Enzyme replacement in Fabry disease: treatment of cultured skin fibroblasts with a purified alpha-galactosidase from ficin. Birth Defects Orig Artic Ser. 1973 Mar;9(2):97–101. [PubMed] [Google Scholar]
  9. Desnick R. J., Allen K. Y., Simmons R. L., Woods J. E., Anderson C. F., Najarian J. S., Krivit W. Fabry disease: correction of the enzymatic deficiency by renal transplantation. Birth Defects Orig Artic Ser. 1973 Mar;9(2):88–96. [PubMed] [Google Scholar]
  10. Desnick R. J., Krivit W., Sharp H. L. In utero diagnosis of Sandhoff's disease. Biochem Biophys Res Commun. 1973 Mar 5;51(1):20–24. doi: 10.1016/0006-291x(73)90501-9. [DOI] [PubMed] [Google Scholar]
  11. Frohwein Y. Z., Gatt S. Enzymatic hydrolysis of sphingolipids. VI. Hydrolysis of ceramide glycosides by calf brain beta-N-acetylhexosaminidase. Biochemistry. 1967 Sep;6(9):2783–2787. doi: 10.1021/bi00861a019. [DOI] [PubMed] [Google Scholar]
  12. Gatt S., Barenholz Y. Enzymes of complex lipid metabolism. Annu Rev Biochem. 1973;42(0):61–90. doi: 10.1146/annurev.bi.42.070173.000425. [DOI] [PubMed] [Google Scholar]
  13. HERS H. G. INBORN LYSOSOMAL DISEASES. Gastroenterology. 1965 May;48:625–633. [PubMed] [Google Scholar]
  14. Harzer K., Benz H. U. Letters: A simple sphingomyelinase determination for Niemann-Pick disease: differential diagnosis of types A, B and C. J Neurochem. 1973 Oct;21(4):999–1001. doi: 10.1111/j.1471-4159.1973.tb07545.x. [DOI] [PubMed] [Google Scholar]
  15. Harzer K. Inheritance of the enzyme deficiency in three neurolipidoses: variant 0 of Tay-Sachs disease (Sandhoff's disease), classic Tay-Sachs disease, and metachromatic leukodystrophy. Identification of the heterozygous carriers. Humangenetik. 1973;20(1):9–24. doi: 10.1007/BF00280871. [DOI] [PubMed] [Google Scholar]
  16. Harzer K., Sandhoff K. Age-dependent variations of the human N-acetyl- -D-hexosaminidases. J Neurochem. 1971 Nov;18(11):2041–2050. doi: 10.1111/j.1471-4159.1971.tb05063.x. [DOI] [PubMed] [Google Scholar]
  17. Harzer K., Sandhoff K., Schall H., Kollmann F. Enzymatische Untersuchungen im Blut von Uberträgern einer Variante der Tay-Sachsschen Erkrankung (Variante O. Klin Wochenschr. 1971 Nov 1;49(21):1189–1191. doi: 10.1007/BF01732464. [DOI] [PubMed] [Google Scholar]
  18. Harzer K., Stinshoff K., Mraz W., Jatzkewitz H. The patterns of arylsulphatases A and B in human normal and metachromatic leucodystrophy tissues and their relationship to the cerebroside sulphatase activity. J Neurochem. 1973 Feb;20(2):279–287. doi: 10.1111/j.1471-4159.1973.tb12127.x. [DOI] [PubMed] [Google Scholar]
  19. Hultberg B. N-acetylhexosaminidase activities in Tay-Sachs disease. Lancet. 1969 Nov 29;2(7631):1195–1195. doi: 10.1016/s0140-6736(69)92520-3. [DOI] [PubMed] [Google Scholar]
  20. JATZKEWITZ H. Zwei Typen von Cerebrosid-schwefelsäureestern als sog. Prälipoide und Speichersubstanzen bei der Leukodystrophie, Typ Scholz (metachromatische Form der diffusen Sklerose). Hoppe Seylers Z Physiol Chem. 1958;311(4-6):279–282. [PubMed] [Google Scholar]
  21. Jatzkewitz H., Mehl E. Cerebroside-sulphatase and arylsulphatase A deficiency in metachromatic leukodystrophy (ML). J Neurochem. 1969 Jan;16(1):19–28. doi: 10.1111/j.1471-4159.1969.tb10339.x. [DOI] [PubMed] [Google Scholar]
  22. Jatzkewitz H., Stinshoff K. An activator of cerebroside sulphatase in human normal liver and in cases of congenital metachromatic leukodystrophy. FEBS Lett. 1973 May 15;32(1):129–131. doi: 10.1016/0014-5793(73)80754-9. [DOI] [PubMed] [Google Scholar]
  23. Johnson W. G., Desnick R. J., Long D. M., Sharp H. L., Krivit W., Brady B., Brady R. O. Intravenous injection of purified hexosaminidase A into a patient with Tay-Sachs disease. Birth Defects Orig Artic Ser. 1973 Mar;9(2):120–124. [PubMed] [Google Scholar]
  24. Kihara H., Porter M. T., Fluharty A. L. Enzyme replacement in cultured fibroblasts from metachromatic leukodystrophy. Birth Defects Orig Artic Ser. 1973 Mar;9(2):19–26. [PubMed] [Google Scholar]
  25. Kolodny E. H., Brady R. O., Volk B. W. Demonstration of an alteration of ganglioside metabolism in Tay-Sachs disease. Biochem Biophys Res Commun. 1969 Oct 22;37(3):526–531. doi: 10.1016/0006-291x(69)90947-4. [DOI] [PubMed] [Google Scholar]
  26. Kolodny E. H., Milunsky A., Sheng G. S. Gm2-gangliosidosis: studies in cultured fibroblasts. Birth Defects Orig Artic Ser. 1973 Mar;9(2):130–135. [PubMed] [Google Scholar]
  27. Krivit W., Desnick R. J., Lee J., Moller J., Wright F., Sweeley C. C., Snyder P. D., Jr, Sharp H. L. Generalized accumulation of neutral glycosphingolipids with GM2 ganglioside accumulation in the brain. Sandhoff's disease (variant of Tay-Sachs disease). Am J Med. 1972 Jun;52(6):763–770. doi: 10.1016/0002-9343(72)90082-4. [DOI] [PubMed] [Google Scholar]
  28. Li Y. T., Mazzotta M. Y., Wan C. C., Orth R., Li S. C. Hydrolysis of Tay-Sachs ganglioside by beta-hexosaminidase A of human liver and urine. J Biol Chem. 1973 Nov 10;248(21):7512–7515. [PubMed] [Google Scholar]
  29. MEHL E., JATZKEWITZ H. EVIDENCE FOR THE GENETIC BLOCK IN METACHROMATIC LEUCODYSTROPHY (ML). Biochem Biophys Res Commun. 1965 May 3;19:407–411. doi: 10.1016/0006-291x(65)90137-3. [DOI] [PubMed] [Google Scholar]
  30. Mapes C. A., Anderson R. L., Sweeley C. C., Desnick R. J., Krivit W. Enzyme replacement in Fabry's disease, an inborn error of metabolism. Science. 1970 Sep 4;169(3949):987–989. doi: 10.1126/science.169.3949.987. [DOI] [PubMed] [Google Scholar]
  31. Mehl E., Jatzkewitz H. Cerebroside 3-sulfate as a physiological substrate of arylsulfatase A. Biochim Biophys Acta. 1968 Mar 25;151(3):619–627. doi: 10.1016/0005-2744(68)90008-9. [DOI] [PubMed] [Google Scholar]
  32. Mehl E., Jatzkewitz H. Eine Cerebrosidsulfatase aus Schweineniere. Hoppe Seylers Z Physiol Chem. 1964;339(1):260–276. [PubMed] [Google Scholar]
  33. Menkes J. H., O'Brien J. S., Okada S., Grippo J., Andrews J. M., Cancilla P. A. Juvenile GM2 gangliosidosis. Biochemical and ultrastructural studies on a new variant of Tay-Sachs disease. Arch Neurol. 1971 Jul;25(1):14–22. doi: 10.1001/archneur.1971.00490010024003. [DOI] [PubMed] [Google Scholar]
  34. Navon R., Padeh B., Adam A. Apparent deficiency of hexosaminidase A in healthy members of a family with Tay-Sachs disease. Am J Hum Genet. 1973 May;25(3):287–293. [PMC free article] [PubMed] [Google Scholar]
  35. O'Brien J. S., Okada S., Ho M. W., Fillerup D. L., Veath M. L., Adams K. Ganglioside storage diseases. Fed Proc. 1971 May-Jun;30(3):956–969. [PubMed] [Google Scholar]
  36. Okada S., McCrea M., O'Brien J. S. Sandhoff's disease (GM 2 gangliosidosis type 2): clinical, chemical, and enzyme studies in five patients. Pediatr Res. 1972 Jul;6(7):606–615. [PubMed] [Google Scholar]
  37. Okada S., O'Brien J. S. Tay-Sachs disease: generalized absence of a beta-D-N-acetylhexosaminidase component. Science. 1969 Aug 15;165(3894):698–700. doi: 10.1126/science.165.3894.698. [DOI] [PubMed] [Google Scholar]
  38. Percy A. K., Kaback M. M. Infantile and adult-onset metachromatic leukodystrophy. Biochemical comparisons and predictive diagnosis. N Engl J Med. 1971 Sep 30;285(14):785–787. doi: 10.1056/NEJM197109302851407. [DOI] [PubMed] [Google Scholar]
  39. Philippart M. Fabry disease: kidney transplantation as an enzyme replacement technic. Birth Defects Orig Artic Ser. 1973 Mar;9(2):81–87. [PubMed] [Google Scholar]
  40. Philippart M., Franklin S. S., Gordon A. Reversal of an inborn sphingolipidosis (Fabry's disease) by kidney transplantation. Ann Intern Med. 1972 Aug;77(2):195–200. doi: 10.7326/0003-4819-77-2-195. [DOI] [PubMed] [Google Scholar]
  41. Pilz H., Hopf H. C. A preclinical case of late adult metachromatic leukodystrophy? Manifestation only with lipid abnormalities in urine, enzyme deficiency and decrease of nerve conduction velocity. J Neurol Neurosurg Psychiatry. 1972 Jun;35(3):360–364. doi: 10.1136/jnnp.35.3.360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Pilz H. Late adult metachromatic leukodystrophy. Arylsulfatase A activity of leukocytes in two families. Arch Neurol. 1972 Jul;27(1):87–90. doi: 10.1001/archneur.1972.00490130089013. [DOI] [PubMed] [Google Scholar]
  43. Porter M. T., Fluharty A. L., Kihara H. Correction of abnormal cerebroside sulfate metabolism in cultured metachromatic leukodystrophy fibroblasts. Science. 1971 Jun 18;172(3989):1263–1265. doi: 10.1126/science.172.3989.1263. [DOI] [PubMed] [Google Scholar]
  44. Porter M. T., Fluharty A. L., Trammell J., Kihara H. A correlation of intracellular cerebroside sulfatase activity in fibroblasts with latency in metachromatic leukodystrophy. Biochem Biophys Res Commun. 1971 Aug 6;44(3):660–666. doi: 10.1016/s0006-291x(71)80134-1. [DOI] [PubMed] [Google Scholar]
  45. Robinson D., Stirling J. L. N-Acetyl-beta-glucosaminidases in human spleen. Biochem J. 1968 Apr;107(3):321–327. doi: 10.1042/bj1070321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. SVENNERHOLM L. The chemical structure of normal human brain and Tay-Sachs gangliosides. Biochem Biophys Res Commun. 1962 Nov 27;9:436–441. doi: 10.1016/0006-291x(62)90030-x. [DOI] [PubMed] [Google Scholar]
  47. Sandhoff K., Andreae U., Jatzkewitz H. Deficient hexosaminidase activity in an exceptional case of Tay-Sachs disease with additional storage of kidney globoside in visceral organs. Pathol Eur. 1968;3(2):278–285. [PubMed] [Google Scholar]
  48. Sandhoff K. Auftrennung der Säuger-N-Acetyl-beta-D-hexosaminidase in multiple Formen durch Elektrofokusserung. Hoppe Seylers Z Physiol Chem. 1968 Sep;349(9):1095–1098. [PubMed] [Google Scholar]
  49. Sandhoff K., Harzer K., Wässle W., Jatzkewitz H. Enzyme alterations and lipid storage in three variants of Tay-Sachs disease. J Neurochem. 1971 Dec;18(12):2469–2489. doi: 10.1111/j.1471-4159.1971.tb00204.x. [DOI] [PubMed] [Google Scholar]
  50. Sandhoff K. Multiple human hexosaminidases. Birth Defects Orig Artic Ser. 1973 Mar;9(2):214–222. [PubMed] [Google Scholar]
  51. Sandhoff K. The hydrolysis of Tay-Sachs ganglioside (TSG) by human N-acetyl-beta-D-hexosaminidase A. FEBS Lett. 1970 Dec 18;11(5):342–344. doi: 10.1016/0014-5793(70)80564-6. [DOI] [PubMed] [Google Scholar]
  52. Sandhoff K. Variation of beta-N-acetylhexosaminidase-pattern in Tay-Sachs disease. FEBS Lett. 1969 Aug;4(4):351–354. doi: 10.1016/0014-5793(69)80274-7. [DOI] [PubMed] [Google Scholar]
  53. Sandhoff K., Wässle W. Anreicherung und Charakterisierung zweier Formen der menschlichen N-acetyl- -D-hexosaminidase. Hoppe Seylers Z Physiol Chem. 1971 Aug;352(8):1119–1133. [PubMed] [Google Scholar]
  54. Srivastava S. K., Beutler E. Antibody against purified human hexosaminidase B cross-reacting with human hexosaminidase A. Biochem Biophys Res Commun. 1972 May 26;47(4):753–759. doi: 10.1016/0006-291x(72)90556-6. [DOI] [PubMed] [Google Scholar]
  55. Srivastava S. K., Beutler E. Hexosaminidase-A and hexosaminidase-B: studies in Tay-Sachs' and Sandhoff's disease. Nature. 1973 Feb 16;241(5390):463–463. doi: 10.1038/241463a0. [DOI] [PubMed] [Google Scholar]
  56. Sugita M., Dulaney J. T., Moser H. W. Ceramidase deficiency in Farber's disease (lipogranulomatosis). Science. 1972 Dec 8;178(4065):1100–1102. doi: 10.1126/science.178.4065.1100. [DOI] [PubMed] [Google Scholar]
  57. Suzuki K., Rapin I., Suzuki Y., Ishii N. Juvenile GM2-gangliosidosis. Clinical variant of Tay-Sachs disease or a new disease. Neurology. 1970 Feb;20(2):190–204. doi: 10.1212/wnl.20.2.190. [DOI] [PubMed] [Google Scholar]
  58. Suzuki Y., Suzuki K. Partial deficiency of hexosaminidase component a in juvenile gm2-gangliosidosis. Neurology. 1970 Sep;20(9):848–851. doi: 10.1212/wnl.20.9.848. [DOI] [PubMed] [Google Scholar]
  59. Tallman J. F., Jr, Brady R. O., Suzuki K. Enzymic activities associated with membranous cytoplasmic bodies and isolated brain lysosomes. J Neurochem. 1971 Sep;18(9):1775–1777. doi: 10.1111/j.1471-4159.1971.tb03754.x. [DOI] [PubMed] [Google Scholar]
  60. Vidgoff J., Buist N. R., O'Brien J. S. Absence of -N-acetyl-D-hexosaminidase A activity in a healthy woman. Am J Hum Genet. 1973 Jul;25(4):372–381. [PMC free article] [PubMed] [Google Scholar]
  61. Young E. P., Ellis R. B., Lake B. D., Patrick A. D. Tay-sachs disease and related disorders: Fractionation of brain N-acetyl-beta-hexosaminidase on DEAE-cellulose. FEBS Lett. 1970 Jul 15;9(1):1–4. doi: 10.1016/0014-5793(70)80295-2. [DOI] [PubMed] [Google Scholar]
  62. Zerfowski J., Sandhoff K. Juvenile GM2-gangliosidose mit veränderter Substratspezifität der Hexosaminidase A. Acta Neuropathol. 1974 Mar 26;27(3):225–232. doi: 10.1007/BF00687632. [DOI] [PubMed] [Google Scholar]
  63. van Someren H., Beijersbergen van Henegou Independent loss of human hexosaminidases A and B in man-chinese hamster somatic cell hybrids. Humangenetik. 1973 Apr 16;18(2):171–174. doi: 10.1007/BF00291485. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology. Supplement (Royal College of Pathologists). are provided here courtesy of BMJ Publishing Group

RESOURCES